ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,948, issued on Aug. 26, was assigned to RHODES TECHNOLOGIES (Coventry, R.I.).
"Pharmaceutical compositions for the treatment of ophthalmic conditions" was invented by Ping Chang (Waterford, Conn.), Zhenze Hu (Davie, Fla.) and Yuanyuan Tao (Drexel Hill, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides emulsion compositions comprising at least one cannabinoid compound, and methods for making the same. The emulsion compositions are stable, well tolerated and are capable of delivering therapeutically effective amounts of cannabiniods to target sites, including sites on the surface of and/or within an eye. Also provided are metho...